Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep906 | Pituitary - Clinical | ECE2016

Quality of life in patients with acromegaly and the effect of somatostatin analogues

Kaldrymidis Dimitrios , Papadakis Georgios , Tsakonas Georgios , Kostoglou-Athanassiou Ifigenia , Kaldrymidis Philippos , Peppa Melpomeni , Roussou Paraskevi , Diamanti-Kandarakis Evanthia

Objective: Quality of life is currently considered a major factor in the assessment of disease outcome. The aim was to assess quality of life in acromegaly and the effect of somatostatin analogues on it.Design: This study included 101 patients with acromegaly, mean age 59.51±1.35 years (mean ± S.E.M.), with a disease duration of 12.88±0.96 years. All subjects completed the Acromegaly Quality of Life Questionnaire (AcroQoL) w...

ea0041ep890 | Pituitary - Clinical | ECE2016

High incidence of thyroid cancer among patients with acromegaly

Kaldrymidis Dimitrios , Papadakis Georgios , Tsakonas Georgios , Kaldrymidis Philippos , Flaskas Theofanis , Seretis Andreas , Pantazi Eleni , Kostoglou-Athanassiou Ifigenia , Peppa Melpomeni , Roussou Paraskevi , Diamanti-Kandarakis Evanthia

Introduction: Several studies have suggested that patients with acromegaly have an increased risk of thyroid, colorectal, breast and prostate tumors. We determined the prevalence of malignant neoplasms in patients with acromegaly in a single Greek Centre during the years 1995–2015.Methods: We evaluated cancer risk in a cohort of 110 patients (M/F 48/62, age 58.63±13.8 years, range 30–86) with acromegaly. Mean age at diagnosis of acromegaly...

ea0035p1047 | Thyroid (non-cancer) | ECE2014

Study of thyroid function during pregnancy in a random population of Northern Greece

Kourtis Anargyros , Xanthopoulou Eleni , Makedou Kali , Slavakis Aristides , Mane Vasileia , Rakintzi Pantelitsa , Delkos Dimitrios , Rousso David

It is well established that overt maternal hypothyroidism and subclinical hypothyroidism may be associated with an adverse outcomes for both the mother and offspring. Therefore, maternal hypothyroidism should be early diagnosed and treated.Aim: The present study was designed in order to investigate thyroid function in the three trimesters of pregnancy, according to the recently updated guidelines.Materials and methods: One hundred ...

ea0032p370 | Diabetes | ECE2013

Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum

Gkiomisi Athina , Makedou Kali , Anastasilakis Athanasios , Polyzos Stergios , Kourtis Anargyros , Gerou Spyridon , Gavana Elpida , Dagklis Themistoklis , Rousso David , Giannoulis Charalambos

Although vaspin is regarded an insulin-sensitizing adipokine, its role in gestational diabetes mellitus (GDM) is currently unknown. We aimed to evaluate serum vaspin levels and their correlation with insulin resistance in women with and without GDM. Forty-four women with GDM (GDM Group 20 managed with diet only (GDM-diet) and 24 with diet plus insulin (GDM-insulin)) and 44 age-matched pregnant women with normal glucose tolerance (control group) were studied. Serum glucose, lip...

ea0011p407 | Diabetes, metabolism and cardiovascular | ECE2006

Urocortin 2 mediates glucose utilization and insulin sensitivity in skeletal muscle

Chen A , Brar B , Choi CS , Rousso D , Vaughan J , Donaldson C , Smith S , Li C , Kim SN , Nagy T , Shulman G , Lee KF , Vale W

Skeletal muscle is the principal tissue responsible for insulin-stimulated glucose disposal and is thus the major site of peripheral insulin resistance. Urocortin 2 (Ucn2), a corticotropin releasing factor (CRF) family member and the type 2 CRF receptor (CRFR2) are highly expressed in skeletal muscle. To determine the physiological role of Ucn2, we generated mice deficient in this peptide. Using glucose and insulin tolerance tests and hyperinsulinemic euglycemic glucose clamp ...